NICE Guidelines for Managing Diabetes


NICE guidelines support the use of flash glucose monitoring for all adults with T1DM or selected adults with T2DM on MDI.*

* T1DM (Type 1 Diabetes) | T2DM (Type 2 Diabetes) | MDI (multiple daily insulin injections)

HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system
HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system
HCP talking to their patient about how the NICE guidelines can be used with the FreeStyle Libre system

NICE guidelines were updated in April 2022

What does this mean for you and your patients?

Adults with T1DM

NICE guidelines support the use of the FreeStyle Libre 2 system or the FreeStyle Libre 3 system in all adults aged 18 and over with T1DM.1

Offer the FreeStyle Libre 2 system or the FreeStyle Libre 3 system to adults with T1DM

Adults with T2DM on MDI

NICE guidelines also support the use of the FreeStyle Libre 2 system in selected adults with T2DM on MDI.2 The FreeStyle Libre 2 system should be offered to adults with insulin-treated T2DM that meet any one of the below criteria:

  • they have recurrent hypoglycaemia or severe hypoglycaemia
  • they have impaired hypoglycaemia awareness
  • they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
  • they would otherwise be advised to self-measure at least 8 times a day

Offer the FreeStyle Libre 2 system to adults with insulin-treated T2DM who would otherwise need help from a care worker or healthcare professional to monitor their blood glucose.

 

Meet the FreeStyle Libre systems

The FreeStyle Libre 2 system helps your patients confidently manage their diabetes

FreeStyle Libre 2 system can empower and support more of your patients to live their best lives. 

The FreeStyle Libre 2 system allows patients to monitor their glucose levels without the need for routine finger prick testing, and is proven to decrease HbA1c in people with T1DM3 and T2DM on MDI.4

  • Real-time glucose readings automatically^ updated every minute and sent directly to your patients’ smartphone
  • Excellent 14-day accuracy5— no more finger pricks
  • Easy to apply and comfortable6 to wear for up to 14 days

FreeStyle Libre 2 system

It's easy to get your patients started on the FreeStyle Libre 2 system

Abbott are here to support you and your patients via our dedicated website which contains helpful resources to support you in onboarding your patients. Plus all the essential information you need on the FreeStyle Libre 2 system. 

FreeStyle Libre 3 is the next-gen CGM performance you can count on

The FreeStyle Libre 3 system is the next-gen CGM performance you can count on with the world’s smallest, thinnest7, and most discreet8 sensor.

The FreeStyle Libre 3 system: 

  • Readings13 are updated 5x faster than other CGMs9

  • Outperforms other CGMs in connectivity8,10,12

  • Most accurate and reliable 14-day CGM, with overall MARD of 7.8%8,10-12

FreeStyle Libre 3 system and logo with the FreeStyle Libre 3 app shown on a smartphone

 

NICE now recommends HCL

for managing glucose levels in type 1 diabetes14,15,16

This means more Type 1 patients qualify for Hybrid Closed Loop compatible systems like the FreeStyle Libre 3 sensor, which is authorised to work with mylife loop system.17

 Teen boy with sensor holding a ball

Access to the FreeStyle Libre Portfolio

The FreeStyle Libre systems exist to empower those living with diabetes to make diabetes self-management choices and to help you, as their healthcare professional, to support them in their journey. 

If you require further information on accessing The FreeStyle Libre systems in your area, the Abbott Market Access Team can support you through this process.

A man sitting in front of a laptop and checking his smartphone.

Contact the Market Access Team

As a registered Healthcare Professional by completing the form below an Abbott representative will contact you regarding your enquiry.

Please provide a valid first name.
Please enter a valid last name.
Please enter the email address.
The subject of your message must not contain special characters.
Please enter a message.

Required fields are indicated with an asterisk (*).

Be at the forefront of diabetes care

Everything you need to know about the FreeStyle Libre 2 system and supporting your patients with diabetes, all in one place

FreeStyle Academy

Educational modules created specifically for Healthcare Professionals.

Webinars

On-demand and live webinars.

Case Studies

Read real-life case studies from Type 1 and Type 2 FreeStyle Libre system users.

Tutorial Videos

On-demand videos demonstrating how to use FreeStyle Libre products and apps.

References & Disclaimers

Images are for illustrative purposes only. Not actual patient data.

1. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed Jan 2023.

2. NICE guideline NG28 (2015) Last updated: 29 June 2022; available at https://www.nice.org.uk/guidance/ng28. Accessed Jan 2023.

3. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.

4. Yaron, M et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.

5. Alva, S. J Diabetes Sci Technol. (2020): https://doi. org/10.1177%2F1932296820958754.

6. Haak, T. Diabetes Ther. (2017): https://doi.org/ 10.1007/s13300-016-0223-6.

7. Among patient-applied sensors.

8. Data on file, Abbott Diabetes Care, Inc.

9. Dexcom G6 CGM User Guide and Medtronic. Guardian Connect System User Guide.

10. Based on signal range in Dexcom G6 User Guide and Medtronic Guardian Connect System User Guide.

11. FreeStyle Libre 3 User Manual. FreeStyle Libre 3 demonstrates 7.8% overall MARD with 7.5% adult MARD and 8.6% pediatric MARD (age 6-17) in accuracy to YSI.

12. Comparison based on publicly available information, CGM reliability defined by signal connection.

13. FreeStyle Libre 2 and FreeStyle Libre 3 systems are part of the same family of products.

14. An HCL system consists of a continuous glucose monitor (CGM) sensor, a control algorithm and an insulin pump. 

15. NICE [2023] Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. [GID-TA10845]. Visit www.nice.org.uk.

16. Only use hybrid closed loop systems with the support of a trained multidisciplinary team experienced in continuous subcutaneous insulin infusion and continuous glucose monitoring in type 1 diabetes. Only use hybrid closed loop systems if the person or their carer is able to use them, and is offered approved face-to-face or digital structured education programmes or is competent in insulin dosing and adjustments. 

17. FreeStyle Libre 3 is authorised to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS FX app and mylife YpsoPump insulin pump. For use of FreeStyle Libre 3 sensor with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

^ Glucose readings are automatically displayed in the FreeStyle LibreLink app only when your patients’ smartphone and sensor are connected and in range.

◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.

Loading...